Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 1

1(20.0%)

5Total

N/A(4)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT01911091Not ApplicableActive Not Recruiting

Identification of Novel Skeletal Muscle-derived Factors That Promote Lipid Oxidation (Columbus)

Role: collaborator

NCT02728635Not ApplicableActive Not Recruiting

Epigenetic Regulation of Human Adipose Tissue Distribution

Role: collaborator

NCT04199000Recruiting

Clinical and Basic Investigations Into Congenital Disorders of Glycosylation

Role: collaborator

NCT01745471Active Not Recruiting

Adipose Tissue and Polycystic Ovary Syndrome (PCOS)(EIFFEL)

Role: collaborator

NCT03032627Not ApplicableActive Not Recruiting

Identifying Targets of Maladaptive Metabolic Responses in Heart Failure

Role: collaborator

NCT02835859Not ApplicableCompleted

Intestinal Sweet Taste Receptor Function and Adaptation to Dietary Sugars and Sweeteners

Role: collaborator

NCT02211651Completed

Maternal Adipose Tissue and Placental Dysfunction Programs the Fetus for Type 2 Diabetes (PlacentA-DM)

Role: collaborator

NCT02226640Completed

Uncovering the 'ORIGINS' of Diabetes

Role: collaborator

NCT01977859Phase 1Completed

BNP Pharmacodynamics and Effects on Metabolism in Lean and Obese Subjects

Role: collaborator

All 9 trials loaded